Literature DB >> 9684749

Hypolipidemic mechanisms of pectin and psyllium in guinea pigs fed high fat-sucrose diets: alterations on hepatic cholesterol metabolism.

M Vergara-Jimenez1, K Conde, S K Erickson, M L Fernandez.   

Abstract

Studies were conducted to determine whether pectin (PE) or psyllium (PSY) could reverse the high plasma cholesterol and triacylglycerol (TAG) concentrations induced by high fat (HF) or high sucrose (HS) diets and which are the mechanisms involved. Male guinea pigs were fed either a low fat (LF) or a HF diet with 80% of the carbohydrate energy derived from sucrose. Cellulose was used as control. Plasma LDL cholesterol, TAG, apolipoprotein B, and hepatic cholesteryl ester were lower in guinea pigs fed PE and PSY compared to the control group (P < 0.03). In addition, a 45% higher number of hepatic apoB/E receptors was observed by PE and PSY intake. Hepatic ACAT, HMG-CoA reductase, and cholesterol 7alpha-hydroxylase (C7H) activities were higher in the HF compared to the LF groups (P < 0.01). PSY intake with HF resulted in up-regulation of C7H and HMG-CoA reductase activities (P < 0.05). Additional studies measuring the effects of PE and PSY on low density lipoprotein (LDL) transport and very low density lipoprotein (VLDL) secretion were conducted in the HF groups. ApoB secretion was reduced by pectin and psyllium (P < 0.01) intake while LDL fractional catabolic rates were 100% faster in guinea pigs fed PE or PSY. In these studies the extent of the hypolipidemic response was specific to each fiber type and associated with the amount of sucrose. In addition, PSY altered the activity of hepatic enzymes of cholesterol homeostasis in the HF group. These additional effects of PSY might explain the more dramatic changes in plasma lipid levels associated with PSY consumption.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684749

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Soluble fiber and soybean protein reduce atherosclerotic lesions in guinea pigs. Sex and hormonal status determine lesion extension.

Authors:  E Cos; T Ramjiganesh; S Roy; S Yoganathan; R J Nicolosi; M L Fernandez
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

2.  Effects of Lactobacillus plantarum FZU3013-Fermented Laminaria japonica on Lipid Metabolism and Gut Microbiota in Hyperlipidaemic Rats.

Authors:  Jin-Peng Hu; Ting-Ting Zheng; Bin-Fen Zeng; Man-Ling Wu; Rui Shi; Ye Zhang; Li-Jiao Chen; Wen-Jian Cheng; Peng Liang
Journal:  Front Nutr       Date:  2021-12-06

3.  A high-saturated fat diet enriched with phytosterol and pectin affects the fatty acid profile in guinea pigs.

Authors:  Gemma Brufau; Miguel Angel Canela; Magda Rafecas
Journal:  Lipids       Date:  2006-02       Impact factor: 1.880

4.  Lipid-regulating effect of traditional chinese medicine: mechanisms of actions.

Authors:  Wei-Jian Bei; Jiao Guo; Hai-Yun Wu; Yang Cao
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-07       Impact factor: 2.629

5.  Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study.

Authors:  Hiroki Kinoshita; Yasuyuki Ogata
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-08       Impact factor: 2.629

6.  Structural characterization and hypolipidemic activities of purified stigma maydis polysaccharides.

Authors:  Wenwen Deng; Xia Yang; Yuan Zhu; Jiangnan Yu; Ximing Xu
Journal:  Food Sci Nutr       Date:  2019-07-03       Impact factor: 2.863

Review 7.  Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: current understandings and future research priorities.

Authors:  Todd C Rideout; Scott V Harding; Peter Jh Jones; Ming Z Fan
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Hypolipidemic activities of partially deacetylated α-chitin nanofibers/nanowhiskers in mice.

Authors:  Wenbo Ye; Liang Liu; Juan Yu; Shilin Liu; Qiang Yong; Yimin Fan
Journal:  Food Nutr Res       Date:  2018-07-17       Impact factor: 3.894

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.